SDX/d-MPH safe and effective against pediatric ADHD
March 15th 2023In a recent study, positive safety and efficacy outcomes for serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH; Azstarys; KemPharm) were found in children aged 6 years and older with attention-deficit/hyperactivity disorder (ADHD).
2 Clarke Drive
Cranbury, NJ 08512